A Phase I Open Label Study of Panobinostat in combination with Lenalidomide, Bortezomib, and Dexamethasone in patients with relapsed and relapsed/refractory Multiple Myeloma
Administered By
Awarded By
Contributors
- Long, Gwynn Douglas Principal Investigator
Start/End
- June 5, 2014 - June 4, 2024